ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

April 23, 1982

ACR Defends Mammographic Exams For Women 35-40,Says Carcinogenic Threat Is “Small”

July 30, 1976

In Brief: Hutchinson Awarded $8 Million Grant For Pancreatic, Colorectal Cancer Studies

September 18, 1998

Obesity, Faster Weight Gain, Linked To Poor Prognosis

October 28, 2005

New NCAB Chair Seeks Ideas, Opinions On Cancer Priorities

September 23, 1994

In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69

August 12, 1988